Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Myocardial Injury After Noncardiac Surgery. Could Dabigatran Be a First Step in Its Management? PMID: 31401086 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2019 Reference: Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):803-805. doi: 10.1016/j.rec.2019.03.018. Epub 2019 Aug 7. Impact factor: 5.078 Publication type: Editorial in national publication Authors: Alvarez-Garcia, Jesus, de Nadal, Miriam, Popova, Ekaterina et al. DOI: 10.1016/j.rec.2019.03.018 Myocardial Injury After Noncardiac Surgery. Could Dabigatran Be a First Step in Its Management? PMID: 31401086 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2019 Reference: Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):803-805. doi: 10.1016/j.rec.2019.03.018. Epub 2019 Aug 7. Impact factor: Publication type: Editorial in national publication Authors: Alvarez-Garcia, Jesus; de Nadal, Miriam; Popova, Ekaterina et al. DOI: 10.1016/j.rec.2019.03.018 MYO-MRI diagnostic protocols in genetic myopathies. PMID: 31727541 Journal: NEUROMUSCULAR DISORDERS Year: 2019 Reference: Neuromuscul Disord. 2019 Nov;29(11):827-841. doi: 10.1016/j.nmd.2019.08.011. Epub 2019 Sep 16. Impact factor: 2.612 Publication type: Review in international publication Authors: Chardon, Jodi Warman, Diaz-Manera, Jordi, Tasca, Giorgio, Bonnemann, Carsten G, Gomez-Andres, David, Heerschap, Arend, Mercuri, Eugenio, Muntoni, Francesco, Pichiecchio, Anna, Ricci, Enzo et al. DOI: 10.1016/j.nmd.2019.08.011 MYO-MRI diagnostic protocols in genetic myopathies. PMID: 31727541 Journal: NEUROMUSCULAR DISORDERS Year: 2019 Reference: Neuromuscul Disord. 2019 Nov;29(11):827-841. doi: 10.1016/j.nmd.2019.08.011. Epub 2019 Sep 16. Impact factor: Publication type: Review in international publication Authors: Bonnemann, Carsten G; Carlier, Robert Y; Chardon, Jodi Warman; Diaz-Manera, Jordi; Gomez-Andres, David; Hanna, Michael; Heerschap, Arend; Jungbluth, Heinz; Mercuri, Eugenio; Morrow, Jasper M et al. DOI: 10.1016/j.nmd.2019.08.011 Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. PMID: 30861336 Journal: Arthritis & Rheumatology Year: 2019 Reference: Arthritis Rheumatol. 2019 Aug;71(8):1371-1376. doi: 10.1002/art.40883. Epub 2019 Jun 18. Impact factor: 9.002 Publication type: Paper in international publication Authors: Pinal-Fernandez, Iago, Amici, David R, Parks, Cassie A, Derfoul, Assia, Casal-Dominguez, Maria, Pak, Katherine, Yeker, Richard, Plotz, Paul, Milisenda, Jose C, Selva-O'Callaghan, Albert et al. DOI: 10.1002/art.40883 Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. PMID: 30861336 Journal: Arthritis & Rheumatology Year: 2019 Reference: Arthritis Rheumatol. 2019 Aug;71(8):1371-1376. doi: 10.1002/art.40883. Epub 2019 Jun 18. Impact factor: Publication type: Paper in international publication Authors: Albayda, Jemima; Amici, David R; Casal-Dominguez, Maria; Christopher-Stine, Lisa; Corse, Andrea M; Derfoul, Assia; Grau-Junyent, Josep M; Lloyd, Thomas E; Mammen, Andrew L; Milisenda, Jose C et al. DOI: 10.1002/art.40883 Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study. PMID: 30442823 Journal: JOURNAL OF RHEUMATOLOGY Year: 2019 Reference: J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15. Impact factor: 3.634 Publication type: Paper in international publication Authors: Mosca, Marta, Bauhammer, Jutta, Miehle, Nikolaus, Parisi, Simone, Cavagna, Lorenzo, Codullo, Veronica, Montecucco, Carlomaurizio, Lopez-Longo, Francisco Javier, Martinez-Barrio, Julia, Nieto-Gonzalez, Juan Carlos et al. DOI: 10.3899/jrheum.180355 Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study. PMID: 30442823 Journal: JOURNAL OF RHEUMATOLOGY Year: 2019 Reference: J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15. Impact factor: Publication type: Paper in international publication Authors: Araguas, Ernesto Trallero; Barsotti, Simone; Bauhammer, Jutta; Bergner, Raoul; Bertolazzi, Chiara; Bonella, Francesco; Bortoluzzi, Alessandra; Caproni, Marzia; Cassone, Giulia; Castaneda, Santos et al. DOI: 10.3899/jrheum.180355 Nanoparticles as theranostic vehicles in prostate cancer. PMID: 31032309 Journal: Annals of Translational Medicine Year: 2019 Reference: Ann Transl Med. 2019 Mar;7(Suppl 1):S29. doi: 10.21037/atm.2019.01.77. Impact factor: 3.689 Publication type: Editorail in international publication Authors: Morales-Barrera, Rafael, Suarez, Cristina, Mateo, Joaquin, Gonzalez, Macarena, Carles, Joan et al. DOI: 10.21037/atm.2019.01.77 Nanoparticles as theranostic vehicles in prostate cancer. PMID: 31032309 Journal: Annals of Translational Medicine Year: 2019 Reference: Ann Transl Med. 2019 Mar;7(Suppl 1):S29. doi: 10.21037/atm.2019.01.77. Impact factor: Publication type: Editorail in international publication Authors: Carles, Joan; Gonzalez, Macarena; Mateo, Joaquin; Morales-Barrera, Rafael; Suarez, Cristina et al. DOI: 10.21037/atm.2019.01.77 Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. PMID: 31226355 Journal: JOURNAL OF CONTROLLED RELEASE Year: 2019 Reference: J Control Release. 2019 Aug 10;307:108-138. doi: 10.1016/j.jconrel.2019.06.017. Epub 2019 Jun 19. Impact factor: 7.901 Publication type: Paper in international publication Authors: Conniot, Joao, Fourniols, Thibaut, Scomparin, Anna, Martinez-Barriocanal, Agueda, Arango, Diego, Conde, Joao P, Preat, Veronique, Satchi-Fainaro, Ronit, Florindo, Helena F, Moura, Liane I F et al. DOI: 10.1016/j.jconrel.2019.06.017 Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. PMID: 31226355 Journal: JOURNAL OF CONTROLLED RELEASE Year: 2019 Reference: J Control Release. 2019 Aug 10;307:108-138. doi: 10.1016/j.jconrel.2019.06.017. Epub 2019 Jun 19. Impact factor: Publication type: Paper in international publication Authors: Arango, Diego; Carreira, Barbara; Conde, Joao P; Conniot, Joao; Florindo, Helena F; Fourniols, Thibaut; Martinez-Barriocanal, Agueda; Matos, Ana I; Moura, Liane I F; Peres, Carina et al. DOI: 10.1016/j.jconrel.2019.06.017 Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry. PMID: 31399146 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8. Impact factor: 3.687 Publication type: Paper in international publication Authors: Gavin-Blanco, O, Riera-Mestre, Antoni, Mora-Lujan, Jose Maria, Trujillo-Santos, Javier, Del Toro, Jorge, Nieto, Jose Antonio, Pedrajas, Jose Maria, Lopez-Reyes, Raquel, Soler, Silvia, Ballaz, Aitor et al. DOI: 10.1186/s13023-019-1172-8 Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry. PMID: 31399146 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8. Impact factor: Publication type: Paper in international publication Authors: Adarraga, M D; Agud, M; Aibar, M A; Alcalde-Manero, M; Alfonso, J; Amado, C; Arcelus, J I; Ballaz, A; Ballaz, Aitor; Barba, R et al. DOI: 10.1186/s13023-019-1172-8 NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. PMID: 31296491 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Aug;20(8):1148-1159. doi: 10.1016/S1470-2045(19)30326-2. Epub 2019 Jul 8. Impact factor: 35.386 Publication type: Paper in international publication Authors: Wardelmann, Eva, Mangel, Laszlo, Sy-Ortin, Teresa, Hohenberger, Peter, de Baere, Thierry, Le Cesne, Axel, Helfre, Sylvie, Saada-Bouzid, Esma, Borkowska, Aneta, Anghel, Rodica et al. DOI: 10.1016/S1470-2045(19)30326-2 NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. PMID: 31296491 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Aug;20(8):1148-1159. doi: 10.1016/S1470-2045(19)30326-2. Epub 2019 Jul 8. Impact factor: Publication type: Paper in international publication Authors: Agoston, Peter; Anghel, Rodica; Austen, Lyn; Bonvalot, Sylvie; Borkowska, Aneta; Bovee, Judith V M G; Carrere, Sebastien; Co, Ann; de Baere, Thierry; Dema, Sorin et al. DOI: 10.1016/S1470-2045(19)30326-2 Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes? PMID: 31365591 Journal: PLoS One Year: 2019 Reference: PLoS One. 2019 Jul 31;14(7):e0220634. doi: 10.1371/journal.pone.0220634. eCollection 2019. Impact factor: 2.776 Publication type: Paper in international publication Authors: Urrutia, Ines, Martinez, Rosa, Rica, Itxaso, Martinez de LaPiscina, Idoia, Garcia-Castano, Alejandro, Aguayo, Anibal, Calvo, Begona, Castano, Luis, Campos Martorell, Ariadna, Clemente Leon, Maria et al. DOI: 10.1371/journal.pone.0220634 Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes? PMID: 31365591 Journal: PLoS One Year: 2019 Reference: PLoS One. 2019 Jul 31;14(7):e0220634. doi: 10.1371/journal.pone.0220634. eCollection 2019. Impact factor: Publication type: Paper in international publication Authors: Aguayo, Anibal; Calvo, Begona; Campos Martorell, Ariadna; Castano, Luis; Clemente Leon, Maria; Garcia-Castano, Alejandro; Martinez de LaPiscina, Idoia; Martinez, Rosa; Rica, Itxaso; Spanish Pediat Diabet Collaborativ et al. DOI: 10.1371/journal.pone.0220634 Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. PMID: 31402321 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Sep;20(9):1226-1238. doi: 10.1016/S1470-2045(19)30334-1. Epub 2019 Aug 8. Impact factor: 35.386 Publication type: Paper in international publication Authors: Saura, Cristina, Hlauschek, Dominik, Oliveira, Mafalda, Zardavas, Dimitrios, Jallitsch-Halper, Anita, de la Pena, Lorena, Nuciforo, Paolo, Ballestrero, Alberto, Dubsky, Peter, Lombard, Janine M et al. DOI: 10.1016/S1470-2045(19)30334-1 Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. PMID: 31402321 Journal: LANCET ONCOLOGY Year: 2019 Reference: Lancet Oncol. 2019 Sep;20(9):1226-1238. doi: 10.1016/S1470-2045(19)30334-1. Epub 2019 Aug 8. Impact factor: Publication type: Paper in international publication Authors: Ballestrero, Alberto; Bardia, Aditya; Baselga, Jose; Boer, Katalin; Castaneda, Carlos A; Ciruelos, Eva; Colleoni, Marco; de Azambuja, Evandro; de la Pena, Lorena; Dubsky, Peter et al. DOI: 10.1016/S1470-2045(19)30334-1 Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement. PMID: 30710068 Journal: ONCOLOGIST Year: 2019 Reference: Oncologist. 2019 May;24(5):603-611. doi: 10.1634/theoncologist.2018-0228. Epub 2019 Feb 1. Impact factor: 5.252 Publication type: Paper in international publication Authors: Colomer, Ramon, Saura, Cristina, Sanchez-Rovira, Pedro, Pascual, Tomas, Rubio, Isabel T, Burgues, Octavio, Marcos, Lourdes, Rodriguez, Cesar A, Martin, Miguel, Lluch, Ana et al. DOI: 10.1634/theoncologist.2018-0228 Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement. PMID: 30710068 Journal: ONCOLOGIST Year: 2019 Reference: Oncologist. 2019 May;24(5):603-611. doi: 10.1634/theoncologist.2018-0228. Epub 2019 Feb 1. Impact factor: Publication type: Paper in international publication Authors: Burgues, Octavio; Colomer, Ramon; Lluch, Ana; Marcos, Lourdes; Martin, Miguel; Pascual, Tomas; Rodriguez, Cesar A; Rubio, Isabel T; Sanchez-Rovira, Pedro; Saura, Cristina et al. DOI: 10.1634/theoncologist.2018-0228 Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer. PMID: 31835708 Journal: Journal of Clinical Medicine Year: 2019 Reference: J Clin Med. 2019 Dec 11;8(12). pii: jcm8122180. doi: 10.3390/jcm8122180. Impact factor: 5.688 Publication type: Paper in international publication Authors: Lopez-Bonet, Eugeni, Buxo, Maria, Cuyas, Elisabet, Pernas, Sonia, Dorca, Joan, Alvarez, Isabel, Martinez, Susana, Perez-Garcia, Jose Manuel, Batista-Lopez, Norberto, Rodriguez-Sanchez, Cesar A et al. DOI: 10.3390/jcm8122180 Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer. PMID: 31835708 Journal: Journal of Clinical Medicine Year: 2019 Reference: J Clin Med. 2019 Dec 11;8(12). pii: jcm8122180. doi: 10.3390/jcm8122180. Impact factor: Publication type: Paper in international publication Authors: Alvarez, Isabel; Amillano, Kepa; Batista-Lopez, Norberto; Brunet, Joan; Buxo, Maria; Castillo, Laura; Cortes, Javier; Cuyas, Elisabet; Dominguez, Severina; Dorca, Joan et al. DOI: 10.3390/jcm8122180 Pagination First page « First Previous page ‹ Previous … Page 747 Page 748 Page 749 Page 750 Current page 751 Page 752 Page 753 Page 754 Page 755 … Next page Next › Last page Last »
